MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis

William Crowe, Lulu Wang, Zhongwei Zhang, Jasmina Varagic, J. Daniel Bourland, Michael D. Chan, Amyn A Habib, Dawen Zhao

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To assess early changes in brain metastasis in response to whole brain radiotherapy (WBRT) by longitudinal Magnetic Resonance Imaging (MRI). Materials and methods: Using a 7T system, MRI examinations of brain metastases in a breast cancer MDA-MD231-Br mouse model were conducted before and 24 hours after 3 daily fractionations of 4 Gy WBRT. Besides anatomic MRI, diffusion-weighted (DW) MRI and dynamic contrast-enhanced (DCE) MRI were applied to study cytotoxic effect and blood-tumor-barrier (BTB) permeability change, respectively. Results: Before treatment, high-resolution T2-weighted images revealed hyperintense multifocal lesions, many of which (∼50%) were not enhanced on T1-weighted contrast images, indicating intact BTB in the brain metastases. While no difference in the number of new lesions was observed, WBRT-treated tumors were significantly smaller than sham controls (p <.05). DW MRI detected significant increase in apparent diffusion coefficient (ADC) in WBRT tumors (p <.05), which correlated with elevated caspase 3 staining of apoptotic cells. Many lesions remained non-enhanced post WBRT. However, quantitative DCE MRI analysis showed significantly higher permeability parameter, Ktrans, in WBRT than the sham group (p <.05), despite marked spatial heterogeneity. Conclusions: MRI allowed non-invasive assessments of WBRT induced changes in BTB permeability, which may provide useful information for potential combination treatment.

Original languageEnglish (US)
JournalInternational Journal of Radiation Biology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Brain Neoplasms
Radiotherapy
Magnetic Resonance Imaging
Breast Neoplasms
Neoplasm Metastasis
Brain
Permeability
Diffusion Magnetic Resonance Imaging
Neoplasms
Caspase 3
Staining and Labeling
Therapeutics

Keywords

  • blood-tumor-barrier (BTB)
  • Brain metastasis
  • diffusion-weighted (DW) MRI
  • dynamic contrast-enhanced (DCE) MRI
  • volume transfer coefficient Ktrans
  • whole brain radiotherapy (WBRT)

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis. / Crowe, William; Wang, Lulu; Zhang, Zhongwei; Varagic, Jasmina; Bourland, J. Daniel; Chan, Michael D.; Habib, Amyn A; Zhao, Dawen.

In: International Journal of Radiation Biology, 01.01.2018.

Research output: Contribution to journalArticle

Crowe, William ; Wang, Lulu ; Zhang, Zhongwei ; Varagic, Jasmina ; Bourland, J. Daniel ; Chan, Michael D. ; Habib, Amyn A ; Zhao, Dawen. / MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis. In: International Journal of Radiation Biology. 2018.
@article{ebf3ee46b3de4fc59979bef959359ff1,
title = "MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis",
abstract = "Purpose: To assess early changes in brain metastasis in response to whole brain radiotherapy (WBRT) by longitudinal Magnetic Resonance Imaging (MRI). Materials and methods: Using a 7T system, MRI examinations of brain metastases in a breast cancer MDA-MD231-Br mouse model were conducted before and 24 hours after 3 daily fractionations of 4 Gy WBRT. Besides anatomic MRI, diffusion-weighted (DW) MRI and dynamic contrast-enhanced (DCE) MRI were applied to study cytotoxic effect and blood-tumor-barrier (BTB) permeability change, respectively. Results: Before treatment, high-resolution T2-weighted images revealed hyperintense multifocal lesions, many of which (∼50{\%}) were not enhanced on T1-weighted contrast images, indicating intact BTB in the brain metastases. While no difference in the number of new lesions was observed, WBRT-treated tumors were significantly smaller than sham controls (p <.05). DW MRI detected significant increase in apparent diffusion coefficient (ADC) in WBRT tumors (p <.05), which correlated with elevated caspase 3 staining of apoptotic cells. Many lesions remained non-enhanced post WBRT. However, quantitative DCE MRI analysis showed significantly higher permeability parameter, Ktrans, in WBRT than the sham group (p <.05), despite marked spatial heterogeneity. Conclusions: MRI allowed non-invasive assessments of WBRT induced changes in BTB permeability, which may provide useful information for potential combination treatment.",
keywords = "blood-tumor-barrier (BTB), Brain metastasis, diffusion-weighted (DW) MRI, dynamic contrast-enhanced (DCE) MRI, volume transfer coefficient Ktrans, whole brain radiotherapy (WBRT)",
author = "William Crowe and Lulu Wang and Zhongwei Zhang and Jasmina Varagic and Bourland, {J. Daniel} and Chan, {Michael D.} and Habib, {Amyn A} and Dawen Zhao",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/09553002.2019.1554920",
language = "English (US)",
journal = "International Journal of Radiation Biology",
issn = "0955-3002",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis

AU - Crowe, William

AU - Wang, Lulu

AU - Zhang, Zhongwei

AU - Varagic, Jasmina

AU - Bourland, J. Daniel

AU - Chan, Michael D.

AU - Habib, Amyn A

AU - Zhao, Dawen

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: To assess early changes in brain metastasis in response to whole brain radiotherapy (WBRT) by longitudinal Magnetic Resonance Imaging (MRI). Materials and methods: Using a 7T system, MRI examinations of brain metastases in a breast cancer MDA-MD231-Br mouse model were conducted before and 24 hours after 3 daily fractionations of 4 Gy WBRT. Besides anatomic MRI, diffusion-weighted (DW) MRI and dynamic contrast-enhanced (DCE) MRI were applied to study cytotoxic effect and blood-tumor-barrier (BTB) permeability change, respectively. Results: Before treatment, high-resolution T2-weighted images revealed hyperintense multifocal lesions, many of which (∼50%) were not enhanced on T1-weighted contrast images, indicating intact BTB in the brain metastases. While no difference in the number of new lesions was observed, WBRT-treated tumors were significantly smaller than sham controls (p <.05). DW MRI detected significant increase in apparent diffusion coefficient (ADC) in WBRT tumors (p <.05), which correlated with elevated caspase 3 staining of apoptotic cells. Many lesions remained non-enhanced post WBRT. However, quantitative DCE MRI analysis showed significantly higher permeability parameter, Ktrans, in WBRT than the sham group (p <.05), despite marked spatial heterogeneity. Conclusions: MRI allowed non-invasive assessments of WBRT induced changes in BTB permeability, which may provide useful information for potential combination treatment.

AB - Purpose: To assess early changes in brain metastasis in response to whole brain radiotherapy (WBRT) by longitudinal Magnetic Resonance Imaging (MRI). Materials and methods: Using a 7T system, MRI examinations of brain metastases in a breast cancer MDA-MD231-Br mouse model were conducted before and 24 hours after 3 daily fractionations of 4 Gy WBRT. Besides anatomic MRI, diffusion-weighted (DW) MRI and dynamic contrast-enhanced (DCE) MRI were applied to study cytotoxic effect and blood-tumor-barrier (BTB) permeability change, respectively. Results: Before treatment, high-resolution T2-weighted images revealed hyperintense multifocal lesions, many of which (∼50%) were not enhanced on T1-weighted contrast images, indicating intact BTB in the brain metastases. While no difference in the number of new lesions was observed, WBRT-treated tumors were significantly smaller than sham controls (p <.05). DW MRI detected significant increase in apparent diffusion coefficient (ADC) in WBRT tumors (p <.05), which correlated with elevated caspase 3 staining of apoptotic cells. Many lesions remained non-enhanced post WBRT. However, quantitative DCE MRI analysis showed significantly higher permeability parameter, Ktrans, in WBRT than the sham group (p <.05), despite marked spatial heterogeneity. Conclusions: MRI allowed non-invasive assessments of WBRT induced changes in BTB permeability, which may provide useful information for potential combination treatment.

KW - blood-tumor-barrier (BTB)

KW - Brain metastasis

KW - diffusion-weighted (DW) MRI

KW - dynamic contrast-enhanced (DCE) MRI

KW - volume transfer coefficient Ktrans

KW - whole brain radiotherapy (WBRT)

UR - http://www.scopus.com/inward/record.url?scp=85059741665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059741665&partnerID=8YFLogxK

U2 - 10.1080/09553002.2019.1554920

DO - 10.1080/09553002.2019.1554920

M3 - Article

JO - International Journal of Radiation Biology

JF - International Journal of Radiation Biology

SN - 0955-3002

ER -